Lamotrigine
Rank #177 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$89.0M
Total Cost
1,603,798
Total Claims
$89.0M
Total Cost
35,357
Prescribers
$55
Cost per Claim
177,029
Beneficiaries
2,422,948
30-Day Fills
$2,516
Avg Cost/Provider
45
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$89.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $89.0M total
Top Prescribers of Lamotrigine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Andrew Zillgitt | Neurology | Garden City, MI | 98 | $427K |
| 2 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 164 | $375K |
| 3 | Jessica Locke | Nurse Practitioner | Gainesville, FL | 110 | $352K |
| 4 | Patricia Melville | Nurse Practitioner | East Setauket, NY | 112 | $337K |
| 5 | David Ficker | Neurology | Cincinnati, OH | 80 | $277K |
| 6 | Ignacio Pita Garcia | Neurology | Guaynabo, PR | 158 | $272K |
| 7 | Bethany Thomas | Nurse Practitioner | Philadelphia, PA | 89 | $265K |
| 8 | Jessica Locke | Nurse Practitioner | Gainesville, FL | 97 | $263K |
| 9 | Scott Scheuermann | Nurse Practitioner | Gainesville, FL | 128 | $248K |
| 10 | Kimberly Konieczki | Nurse Practitioner | Erie, PA | 71 | $245K |
| 11 | Olga Taraschenko | Neurology | Omaha, NE | 96 | $244K |
| 12 | Patricia Rogers | Nurse Practitioner | Rochester, NY | 111 | $244K |
| 13 | Hannah Rockett | Nurse Practitioner | Seattle, WA | 93 | $238K |
| 14 | Michael Doherty | Neurology | Seattle, WA | 57 | $236K |
| 15 | Stephan Eisenschenk | Neurology | Gainesville, FL | 39 | $233K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 174 | Mepolizumab (Nucala) | $90.1M | 20,798 |
| 175 | Finerenone (Kerendia) | $89.5M | 93,151 |
| 176 | Ixazomib Citrate (Ninlaro) | $89.0M | 6,901 |
| 177 | Lamotrigine (Lamotrigine) | $89.0M | 1,603,798 |
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology